Friday, October 16, 2026

BTC $82,249 ▲ 0.14%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.230+0.13%ETH$2,472+1.36%LINK$12.62+1.39%SOL$106.34+0.99%BTC$82,249+0.14%XRP$1.34+0.32%S&P 5007,744−0.00%Nasdaq26,578−0.50%Dow52,337+0.31%RUT2,763−0.17%TNX5.08%−0.16%TYX5.42%−0.11%FVX4.88%−0.37%IRX4.07%−0.56%VIX16.08−2.31%GOLD$4,214.20+1.06%SILVER$57.96+1.41%OIL$95.45−1.09%DXY101.63−0.42%NVDA$218.46+0.56%AAPL$344.54+0.74%TSLA$364.12+0.46%META$723.11−1.85%MSFT$536.17−0.61%AMZN$254.32−0.17%GOOGL$346.34−0.83%Fear & Greed63 — GreedADA$0.230+0.13%ETH$2,472+1.36%LINK$12.62+1.39%SOL$106.34+0.99%BTC$82,249+0.14%XRP$1.34+0.32%S&P 5007,744−0.00%Nasdaq26,578−0.50%Dow52,337+0.31%RUT2,763−0.17%TNX5.08%−0.16%TYX5.42%−0.11%FVX4.88%−0.37%IRX4.07%−0.56%VIX16.08−2.31%GOLD$4,214.20+1.06%SILVER$57.96+1.41%OIL$95.45−1.09%DXY101.63−0.42%NVDA$218.46+0.56%AAPL$344.54+0.74%TSLA$364.12+0.46%META$723.11−1.85%MSFT$536.17−0.61%AMZN$254.32−0.17%GOOGL$346.34−0.83%Fear & Greed63 — Greed

Tag

argenx

1 article

U.S. Equities20d ago

Argenx's Vyvgart Franchise Offers 23% Upside; Four Studies Coming

The biotech reported 60% year-over-year revenue growth in Q2 2026 on gMG and CIDP therapies, with Wall Street's consensus target at $1,180.25.